Pharmapack 2023: Session interview – Terumo on integrated CDMO solutions
![](/46/pdcnewsitem/12/03/48/784x590%20news%20header%20-%202023-03-30T104136.110.png)
Pharmapack 2023 showcased a number of sessions on the key topics in the industry, from conference sessions to workshops, presented by experts in the field.
After the session from Terumo on 'Case study of a biosimilar drug launched globally using integrated CDMO Solution' from Anil Busimi, Vice President of Strategy and Marketing, Digital Editor Lucy Chard went on to find out more.
First of all please could you introduce yourself and your company?
My name is Anil Busimi I am the Vice President of Strategy and Marketing for Terumo Pharmaceutical Solutions Division, which is part of Terumo Medical Care Solutions.
Could you please give a brief overview of your presentation here at Pharmapack?
The pharmaceutical solutions division of Terumo Medical Solutions operates under five platforms, going from CDMO, fill and finish services to injection devices, infusion devices and primary packaging like the polymer prefillable syringes (PFS), and new drug delivery devices. My presentation today was focused on a case study that integrated the CDMO service offering with our capabilities of designing and manufacturing primary packaging solutions like a polymer PFS, and how we help our customer to bring this biosimilar product to the market on time and keeping the quality of this product very high.
You spoke in your presentation about focusing on the point of contact of the product with the patient, how important is patient centricity when you’re looking at working with clients and developing products like this?
We are in a B2B setting so we provide our services to pharma companies and biotech companies. So generally, we are not in contact with patients on a day to day basis, however, at Terumo, patient centricity is at the core of everything we do. We go beyond the normal expectation with a company such as ours to generate our own understanding of what is the impact of the devices on the patient, how do they use it? We bring these insights and share them with the pharma companies to help them make the right choices and decisions to address patient centricity and in the end to ensure the efficacy of the drug.
What has changed for you in the last couple of years that has helped you in developing the best possible product and in how you work with your partners?
If you look in the past, such as in my presentation showing the trend moving from a vial to a prefillable syringe, this has in fact been happening over the past 20–30 years. In the last 5 years there has been a lot of emphasis coming from the patient and from the regulatory authorities regarding the human factors and the patient centricity aspect. How do you make sure that you don’t just design products from an engineering perspective for engineers, but rather you design products that are to be used by patients in their particular setting or to treat their ailments. In my presentation the example that I used was for rheumatoid arthritis, so the patients have dexterity problems, patients have difficulty in holding things or doing self-injections. So, you have to really understand who is using this device and what is their environment, and make sure you can design a device that makes it easy for them to adhere to the drug administration. I think that’s one of the aspects that we have seen a lot of emphasis on in the past few years in the industry. Although our contracts are with the pharma companies, it still mandates us as a supplier that we need to understand the patients and how the patients would interact with a particular device and what kinds of insights or designs we can bring to help to make the drug both worthwhile and successful.
What is the benefit for Terumo in doing these workshops? Do you find them helpful for you as a company? What does that bring to the industry?
It is all about sharing the knowledge you know, I think sometimes sharing is the best practice and specifically for us in this presentation, showing some of the challenges we faced means that others don’t have to go through the same pit falls. Especially with our integrated CDMO, which was one of the core messages we shared today, if you are a biosimilar company time is of the essence and dealing with multiple suppliers and multiple partners will make your work complex and you will not meet your targets and I think that by having an example like Terumo with the integrated CDMO approach can help biosimilar companies bring effective and innovative drugs to the market much faster.
Related News
-
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News CPHI Online Webinar Series – The CPO Perspective: Driving Healthcare Sustainability
Pharmaceutical contract packaging organisations (CPOs) offer organisations broader expertise in pharma packaging, specialist skills, and flexibility with time, efficiency, and costings for pharmaceutical companies lacking in-house packaging expert... -
News Pharmapack Europe 2023 Award Winners – ATB West for Patient Centric Design
We interview the winners of the Pharmapack Europe Awards 2023, who were chosen by a jury, and each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainability Initiative, Eco-Design, and Patient-... -
News Pharmapack 2023 – Take the Start-Up innovation tour
At Pharmapack 2023 in Paris we debuted a new and improved Start-Up Hub. The Hub included several start-up companies we are looking to support and make the event more accessible. -
News Pharmapack Europe 2023 Award Winners – PACKSYS GmbH for Packaging Innovation
We interview the winners of the Pharmapack Europe Awards 2023, who were chosen by a jury, and each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainability Initiative, Eco-Design, and Patient-... -
News Women in Pharma – Karin von Kienlin Pharmapack 2023
This year at Pharmapack 2023 in Paris, France, the CPHI Online team interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in this field. -
News Pharmapack 2023: Session interview – BD Pharmaceutical Systems on de-risking combination product development
Pharmapack 2023 showcased a number of sessions on the key topics in the industry, from conference sessions to workshops, presented by experts in the field. -
News Women in Pharma – Asmita Khanolkar Pharmapack 2023
At Pharmapack 2023, the CPHI team interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in this field. Ahead of International Women’s Day on March 8, 2023, we are proud to provide a p...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance